TCTR20211122002招募中4 期
An open-label, pilot study evaluating the efficacy of a lip balm containing panthenol and bisabolol as a monotherapy for the treatment of mild to moderate cheilitis
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand0 个研究点目标入组 20 人开始时间: 2021年11月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Aged 18 years or older
- •2. Patients who were diagnosed with mild to moderate cheilitis by dermatologists
排除标准
- •(i) patients with other dermatologic diseases of the lips, (ii) patients with a history of contact allergy to panthenol and bisabolol, (iii) patients applied topical corticosteroids or topical calcineurin inhibitors at the lips 1 week prior to inclusion, (iv) patients taking oral corticosteroids 2 weeks prior to enrollment, and/or (v) pregnant or lactating patients
研究者
相似试验
进行中（未招募）
1 期
An open label pilot study to evaluate the efficacy and safety of topical tacrolimus 0l1% (Protopic) in the treatment of varicose eczemaEUCTR2004-004467-29-GBCraigavon Area Hospital Group Trust12
招募中
1 期
An open-label pilot trial of N-acetyl cysteine treatment for body dysmorphic disorderBody dysmorphic disorderMental Health - Other mental health disordersACTRN12616001546448St Vincent's Hospital Melbourne20
进行中（未招募）
1 期
A Phase 2, open-label study to assess the efficacy and safety of AK002 in patients with chronic urticaria who do not respond to anithistaminesPatients with different types of chronic urticaria resistant to standard dose antihistaminesMedDRA version: 20.0Level: PTClassification code 10052568Term: Urticaria chronicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2017-002581-51-DEAllakos Inc.48
进行中（未招募）
1 期
A pilot open-label study to assess the efficacy and safety of tocilizumab (TCZ) in patients with active Schnitzler’s syndrome (SchS)Schnitzler’s syndrome (SchS)MedDRA version: 19.1 Level: PT Classification code 10062908 Term: Schnitzler's syndrome System Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2016-003828-23-DECharité - Universitätsmedizin Berlin; Dpt. of Dermatology and Allergy12
招募中
1 期
Clinical study to assess the efficacy and safety of Cannabidiol in children and young adults with rare disease-associated severe epilepsyMedDRA version: 21.0Level: PTClassification code: 10015037Term: Epilepsy Class: 100000004852EpilepsyCTIS2023-503709-12-00Azienda Ospedaliero Universitaria Meyer IRCCS30